Source: Cancer Research. Conference titles: Annual Meeting of the American Association for Cancer Research (AACR). Unidade: FCF
Assunto: MELANOMA
ABNT
FAIÃO-FLORES, Fernanda et al. Targeting hedgehog transcription factors GLl1 and GLl2 restores sensitivity to vemurafenib resistant human melanoma cells. Cancer Research. Philadelphia: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: http://cancerres.aacrjournals.org/content/76/14_supplement/4669.short. Acesso em: 02 nov. 2024. , 2016APA
Faião-Flores, F., Fernandes, D. K. M. A., Pennacchi, P. C., Sandri, S., Vicente, A. L. S. A., Scapulatempo Neto, C., et al. (2016). Targeting hedgehog transcription factors GLl1 and GLl2 restores sensitivity to vemurafenib resistant human melanoma cells. Cancer Research. Philadelphia: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de http://cancerres.aacrjournals.org/content/76/14_supplement/4669.shortNLM
Faião-Flores F, Fernandes DKMA, Pennacchi PC, Sandri S, Vicente ALSA, Scapulatempo Neto C, Vasquez V de L, Reis RMV, Smalley KS, Maria-Engler SS. Targeting hedgehog transcription factors GLl1 and GLl2 restores sensitivity to vemurafenib resistant human melanoma cells [Internet]. Cancer Research. 2016 ; 76( 14):[citado 2024 nov. 02 ] Available from: http://cancerres.aacrjournals.org/content/76/14_supplement/4669.shortVancouver
Faião-Flores F, Fernandes DKMA, Pennacchi PC, Sandri S, Vicente ALSA, Scapulatempo Neto C, Vasquez V de L, Reis RMV, Smalley KS, Maria-Engler SS. Targeting hedgehog transcription factors GLl1 and GLl2 restores sensitivity to vemurafenib resistant human melanoma cells [Internet]. Cancer Research. 2016 ; 76( 14):[citado 2024 nov. 02 ] Available from: http://cancerres.aacrjournals.org/content/76/14_supplement/4669.short